Holly Springs--Novartis.

PositionStatewide

HOLLY SPRINGS -- Novartis will sell its local manufacturing plant to Australia-based pharmaceutical company CSL as part of a $275 million divestiture of its flu vaccines business. The Basel, Switzerland-based company employs about 550 people at the 475,000-square-foot...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT